The paradoxical benefit of sulfonylurea agents in diabetics undergoing coronary revascularization
- PMID: 9857909
The paradoxical benefit of sulfonylurea agents in diabetics undergoing coronary revascularization
Comment on
-
The optimal mode of coronary revascularization for diabetics. A risk-adjusted long-term study comparing coronary angioplasty and coronary bypass surgery.Eur Heart J. 1998 Nov;19(11):1696-703. doi: 10.1053/euhj.1998.1153. Eur Heart J. 1998. PMID: 9857923